Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 63
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Toxicol Appl Pharmacol ; 433: 115779, 2021 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-34737146

RESUMEN

The Delaney Clause of the Federal Food, Drug, and Cosmetic Act became law in 1958 because of concerns that potentially harmful chemicals were finding their way into foods and causing cancer. It states, "[n]o additive shall be deemed to be safe if it is found to induce cancer when ingested by man or animal, or if it is found, after tests which are appropriate for the evaluation of the safety of food additives, to induce cancer in man or animal." The United States Food and Drug Administration (US FDA) and United States Environmental Protection Agency (US EPA, prior to implementation of the Food Quality Protection Act) were charged with implementing this clause. Over 60 years, advances in cancer research have elucidated how chemicals induce cancer. Significant advancements in analytical methodologies have allowed for accurate and progressively lower detection limits, resulting in detection of trace amounts. Based on current scientific knowledge, there is a need to revisit the Delaney Clause's utility. The lack of scientific merit to the Delaney Clause was very apparent when recently the US FDA had to revoke the food additive approvals of 6 synthetic flavoring substances because high dose testing in animals demonstrated a carcinogenic response. However, US FDA determined that these 6 synthetic flavoring substances do not pose a risk to public health under the conditions of intended use. The 7th substance, styrene, was de-listed because it is no longer used by industry. The scientific community is committed to improving public health by promoting relevant science in risk assessment and regulatory decision making, and this was discussed in scientific sessions at the American Association for the Advancement of Science (AAAS) 2020 Annual Meeting and the Society of Toxicology (SOT) 2019 Annual Meeting. Expert presentations included advances in cancer research since the 1950s; the role of the Delaney Clause in the current regulatory paradigm with a focus on synthetic food additives; and the impact of the clause on scientific advances and regulatory decision making. The sessions concluded with panel discussions on making the clause more relevant based on 21st-century science.


Asunto(s)
Pruebas de Carcinogenicidad , Carcinógenos/toxicidad , Aditivos Alimentarios/toxicidad , Legislación Alimentaria , United States Environmental Protection Agency/legislación & jurisprudencia , United States Food and Drug Administration/legislación & jurisprudencia , Animales , Exposición Dietética/efectos adversos , Relación Dosis-Respuesta a Droga , Regulación Gubernamental , Humanos , Formulación de Políticas , Medición de Riesgo , Estados Unidos
2.
Risk Anal ; 40(12): 2584-2597, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33270937

RESUMEN

Methyl tert-butyl ether (MTBE) was added to gasoline in New Hampshire (NH) between 1995 and 2006 to comply with the oxygenate requirements of the 1990 Amendments to the Clean Air Act. Leaking tanks and spills released MTBE into groundwater, and as a result, MTBE has been detected in drinking water in NH. We conducted a comparative cancer risk assessment and a margin-of-safety (MOS) analysis for several constituents, including MTBE, detected in NH drinking water. Using standard risk assessment methods, we calculated cancer risks from exposure to 12 detected volatile organic compounds (VOCs), including MTBE, and to four naturally occurring compounds (i.e., arsenic, radium-226, radium-228, and radon-222) detected in NH public water supplies. We evaluated exposures to a hypothetical resident ingesting the water, dermally contacting the water while showering, and inhaling compounds volatilizing from water in the home. We then compared risk estimates for MTBE to those of the other 15 compounds. From our analysis, we concluded that the high-end cancer risk from exposure to MTBE in drinking water is lower than the risks from all the other VOCs evaluated and several thousand times lower than the risks from exposure to naturally occurring constituents, including arsenic, radium, and radon. We also conducted an MOS analysis in which we compared toxicological points of departure to the NH maximum contaminant level (MCL) of 13 µg/L. All of the MOSs were greater than or equal to 160,000, indicating a large margin of safety and demonstrating the health-protectiveness of the NH MCL for MTBE.


Asunto(s)
Carcinógenos/toxicidad , Agua Potable/química , Éteres Metílicos/toxicidad , Neoplasias/inducido químicamente , Medición de Riesgo , Compuestos Orgánicos Volátiles/toxicidad , Contaminantes Químicos del Agua/toxicidad , Humanos , New Hampshire
3.
Regul Toxicol Pharmacol ; 106: 239-250, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31078680

RESUMEN

Toxicokinetics are important for extrapolating health effects and effect levels observed in laboratory animals to humans for purposes of establishing health-based criteria. We conducted a comprehensive review of key absorption, distribution, metabolism, and excretion (ADME) parameters across different mammalian species for five perfluoroalkyl substances (PFAS) and discussed how these data can be used to inform human health risk assessment of these substances. Our analysis revealed several notable differences among the different PFAS regarding species- and substance-specific tissue partitioning, half-life, and transfer to developing offspring via the placenta or lactation, as well as highlighted data gaps for certain substances. We incorporated these observations in an analysis of whether health-based values for specific PFAS can be applied to other PFAS of differing chain length or toxicological mode of action. Overall, our analysis provides one of the first syntheses of available empirical PFAS toxicokinetic data to facilitate interpreting human relevance of animal study findings and developing health-based criteria for PFAS from such studies.


Asunto(s)
Contaminantes Ambientales/química , Contaminantes Ambientales/toxicidad , Fluorocarburos/química , Fluorocarburos/toxicidad , Monitoreo del Ambiente , Contaminantes Ambientales/clasificación , Contaminantes Ambientales/farmacocinética , Fluorocarburos/clasificación , Fluorocarburos/farmacocinética , Humanos , Medición de Riesgo , Toxicocinética
4.
Inhal Toxicol ; 28(14): 637-657, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27829301

RESUMEN

We examined the development of knowledge concerning the risks posed by asbestos to seamen working aboard merchant ships at sea (i.e. commercial, rather than naval vessels). Seamen were potentially exposed to "in-place" asbestos on merchant ships by performing intermittent repair and maintenance tasks. We reviewed studies measuring airborne asbestos onboard merchant ships and health outcomes of merchant seamen, as well as studies, communications, and actions of U.S. organizations with roles in maritime health and safety. Up to the 1970s, most knowledge of the health risks of asbestos was derived from studies of workers in asbestos product manufacturing and asbestos mining and milling industries, and certain end-users of asbestos products (particularly insulators). We found that attention to the potential health risks of asbestos to merchant seamen began in the mid- to late 1970s and early 1980s. Findings of pleural abnormalities in U.S. seamen elicited some concern from governmental and industry/labor organizations, but airborne asbestos concentrations aboard merchant ships were found to be <1 f/cc for most short-term repair and maintenance tasks. Responses to this evolving information served to warn seamen and the merchant shipping industry and led to increased precautions regarding asbestos exposure. Starting in the 1990s, findings of modest increases in lung cancer and/or mesothelioma in some epidemiology studies of seamen led some authors to propose that a causal link between shipboard exposures and asbestos-related diseases existed. Limitations in these studies, however, together with mostly unremarkable measures of airborne asbestos on merchant ships, preclude definitive conclusions in this regard.


Asunto(s)
Contaminantes Ocupacionales del Aire/historia , Contaminantes Ocupacionales del Aire/toxicidad , Amianto/historia , Amianto/toxicidad , Navíos , Contaminantes Ocupacionales del Aire/análisis , Animales , Amianto/análisis , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Medicina Naval/historia , Enfermedades Profesionales/etiología , Enfermedades Profesionales/historia , Enfermedades Profesionales/prevención & control , Exposición Profesional/efectos adversos , Exposición Profesional/análisis , Exposición Profesional/historia , Exposición Profesional/prevención & control , Salud Laboral , Riesgo
5.
Crit Rev Toxicol ; 43(9): 711-52, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24040994

RESUMEN

Inorganic arsenic (iAs) at high exposures is a human carcinogen, affecting mainly the urinary bladder, lung and skin. We present an assessment of the mode of action (MOA) of iAs's carcinogenicity based on the United States Environmental Protection Agency/International Programme on Chemical Safety (USEPA/IPCS) framework, focusing primarily on bladder cancer. Evidence is presented for a MOA involving formation of reactive trivalent metabolites interacting with critical cellular sulfhydryl groups, leading to cytotoxicity and regenerative cell proliferation. Metabolism, kinetics, cell transport, and reaction with specific proteins play a critical role in producing the effects at the cellular level, regardless of cell type, whether urothelium, lung epithelium or epidermis. The cytotoxicity induced by iAs results in non-cancer toxicities, and the regenerative cell proliferation enhances development of epithelial cancers. In other tissues, such as vascular endothelium, different toxicities develop, not cancer. Evidence supporting this MOA comes from in vitro investigations on animal and human cells, from animal models, and from epidemiological studies. This MOA implies a non-linear, threshold dose-response relationship for both non-cancer and cancer end points. The no effect levels in animal models (approximately 1 ppm of water or diet) and in vitro (>0.1 µM trivalent arsenicals) are strikingly consistent. Cancer effects of iAs in humans generally are not observed below exposures of 100-150 ppb in drinking water: below these exposures, human urine concentrations of trivalent metabolites are generally below 0.1 µM, a concentration not associated with bladder cell cytotoxicity in in vitro or animal models. Environmental exposures to iAs in most of the United States do not approach this threshold.


Asunto(s)
Arsénico/toxicidad , Carcinógenos/toxicidad , Neoplasias de la Vejiga Urinaria/inducido químicamente , Animales , Arsénico/farmacología , Proliferación Celular , Agua Potable , Exposición a Riesgos Ambientales , Humanos , Estados Unidos , Neoplasias de la Vejiga Urinaria/epidemiología
6.
Regul Toxicol Pharmacol ; 65(1): 47-59, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23123333

RESUMEN

Gastrointestinal (GI) symptoms, the primary acute effect of the essential micronutrient copper, paradoxically occur at lower exposure levels than hepatotoxicity, the primary chronic effect. We developed a remedial action criterion (RAC) for copper to protect against GI symptoms, which primarily relate to the stomach copper concentration, and subside within an hour. Using Monte Carlo methods, we generated a distribution of RACs protective against GI symptoms for a 1 h exposure (hourly RACs) based on soil ingestion rate, volume of liquid and food in the stomach, and bioaccessibility. We then generated a distribution of daily RACs, selected as the minimum hourly RAC for each day over a year, constrained by total daily soil ingestion. Next, we identified a percentile of the distribution of daily RACs, and associated RAC, that would result in a high probability of having a minimal number of GI symptom episodes per year. Our analysis indicates that a copper concentration of 3600 mg/kg would result in a 95% probability of having fewer than five episodes of GI symptoms per year, for a child ingesting outdoor soil 180 days per year. Children residing near copper smelters are most likely to experience GI symptoms from ingestion of copper in soil.


Asunto(s)
Cobre/toxicidad , Restauración y Remediación Ambiental/métodos , Contaminantes del Suelo/toxicidad , Suelo/química , Animales , Niño , Exposición a Riesgos Ambientales/prevención & control , Enfermedades Gastrointestinales/inducido químicamente , Enfermedades Gastrointestinales/epidemiología , Enfermedades Gastrointestinales/prevención & control , Humanos , Metalurgia , Método de Montecarlo , Probabilidad , Factores de Tiempo
8.
J Transl Med ; 9: 151, 2011 Sep 13.
Artículo en Inglés | MEDLINE | ID: mdl-21910911

RESUMEN

BACKGROUND: Active dendritic cell (DC) immunization protocols are rapidly gaining interest as therapeutic options in patients with acute myeloid leukemia (AML). Here we present for the first time a GMP-compliant 3-day protocol for generation of monocyte-derived DCs using different synthetic Toll-like receptor (TLR) agonists in intensively pretreated patients with AML. METHODS: Four different maturation cocktails were compared for their impact on cell recovery, phenotype, cytokine secretion, migration, and lymphocyte activation in 20 AML patients and 25 healthy controls. RESULTS: Maturation cocktails containing the TLR7/8 agonists R848 or CL075, with and without the addition of the TLR3 agonist poly(I:C), induced DCs that had a positive costimulatory profile, secreted high levels of IL-12(p70), showed chemotaxis to CCR7 ligands, had the ability to activate NK cells, and efficiently stimulated antigen-specific CD8+ T cells. CONCLUSIONS: Our results demonstrate that this approach translates into biologically improved DCs, not only in healthy controls but also in AML patients. This data supports the clinical application of TLR-matured DCs in patients with AML for activation of innate and adaptive immune responses.


Asunto(s)
Diferenciación Celular , Células Dendríticas/citología , Células Dendríticas/inmunología , Leucemia Mieloide Aguda/inmunología , Leucemia Mieloide Aguda/terapia , Receptores Toll-Like/agonistas , Adulto , Anciano , Biomarcadores/metabolismo , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Quimiocina CCL19/farmacología , Quimiotaxis/efectos de los fármacos , Células Dendríticas/efectos de los fármacos , Células Dendríticas/metabolismo , Femenino , Humanos , Interleucina-10/metabolismo , Interleucina-12/metabolismo , Células Asesinas Naturales/efectos de los fármacos , Células Asesinas Naturales/inmunología , Activación de Linfocitos/efectos de los fármacos , Masculino , Persona de Mediana Edad , Fosfoproteínas/inmunología , Inducción de Remisión , Factores de Tiempo , Receptores Toll-Like/inmunología , Proteínas de la Matriz Viral/inmunología , Adulto Joven
9.
Toxicology ; 456: 152783, 2021 05 30.
Artículo en Inglés | MEDLINE | ID: mdl-33872731

RESUMEN

Our understanding of the etiology of cancer has developed significantly over the past fifty years, beginning with a single-hit linear no-threshold (LNT) conceptual model based on early studies conducted in Drosophila. Over the past several decades, multiple lines of evidence have accumulated to support a contemporary model of chemical carcinogenesis: a multi-hit model involving a prolonged stress environment that over time may drive the mutation of multiple cells into an injured state that ultimately could lead to uncontrolled proliferation via clonal expansion of mutation-carrying daughter cells. Arsenic carcinogenicity offers a useful case study for further exploration of advanced conceptual models for chemical carcinogenesis. A threshold for arsenic carcinogenicity is supported by its mode of action, characterized by repeating cycles of cytotoxicity and cellular regeneration. Furthermore, preliminary meta-analyses of epidemiology dose-response data for inorganic arsenic (iAs) and bladder cancer, correlated to dose-response data measured in vitro, support a threshold of effect in humans on the order of 50-100 µg/L in drinking water. In light of recent developments in our understanding of cancer etiology, we urge strong consideration of the existing mode-of-action evidence supporting a threshold of effect for arsenic carcinogenicity, as well as consideration of the potential methodological pitfalls in evaluating epidemiology dose-response data that could potentially bias in the direction of low-dose linearity.


Asunto(s)
Arsénico/toxicidad , Carcinogénesis/inducido químicamente , Carcinogénesis/genética , Carcinógenos/toxicidad , Proliferación Celular/efectos de los fármacos , ADN/genética , Animales , Carcinogénesis/metabolismo , Proliferación Celular/fisiología , ADN/metabolismo , Agua Potable/efectos adversos , Exposición a Riesgos Ambientales/efectos adversos , Humanos
10.
J Toxicol Environ Health A ; 73(2): 253-60, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20077295

RESUMEN

This article addresses the content of the workshop, including a panel discussion relevant to delineation of a path forward in relation to risk assessment of essential metals. The state of the art of risk assessment and associated issues for essential metals are outlined initially, followed by brief illustration by the case studies considered at the workshop (i.e., copper, zinc, and manganese). Approaches for the future testing strategies of essential metals are discussed in terms of options to increase efficiency and accuracy of assessments. Subsequently, recommendations for pragmatic next steps to advance progress and facilitate uptake by the regulatory risk assessment community are presented.


Asunto(s)
Exposición a Riesgos Ambientales/efectos adversos , Oligoelementos/efectos adversos , Oligoelementos/farmacología , Animales , Relación Dosis-Respuesta a Droga , Humanos , Necesidades Nutricionales , Medición de Riesgo , Roedores , Pruebas de Toxicidad , Oligoelementos/administración & dosificación
11.
Bioorg Med Chem Lett ; 19(14): 3828-31, 2009 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-19435667

RESUMEN

The design, synthesis and preliminary activity of small molecular weight modulators of the heat shock protein 70 (Hsp70) are described. The compounds provide a starting point for the synthesis of novel tools to decipher Hsp70 biology.


Asunto(s)
Proteínas HSP70 de Choque Térmico/química , Péptidos/química , Secuencia de Aminoácidos , Sitios de Unión , Simulación por Computador , Cristalografía por Rayos X , Proteínas HSP70 de Choque Térmico/metabolismo , Modelos Químicos , Péptidos/síntesis química , Péptidos/farmacología , Unión Proteica , Estructura Terciaria de Proteína
12.
J Comb Chem ; 11(4): 631-9, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19548636

RESUMEN

The protein-protein interaction of p53 and mdm2 is an important anticancer target. The interface, however, is very hydrophobic and naturally results in very hydrophobic antagonists. We used the Orru three component reaction (O-3CR) along with a rapid and efficient, recently discovered amidation reaction to dramatically improve the water solubility of our recently discovered low molecular weight p53/mdm2 antagonists. Arrays of amides were synthesized with improved hydrophilicity and retainment and/or improvement of p53/mdm2 inhibitory activity.


Asunto(s)
Amidas/síntesis química , Técnicas Químicas Combinatorias/métodos , Imidazolinas/síntesis química , Proteínas Proto-Oncogénicas c-mdm2/antagonistas & inhibidores , Proteína p53 Supresora de Tumor/antagonistas & inhibidores , Agua/química , Amidas/química , Técnicas Químicas Combinatorias/economía , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Imidazolinas/química , Modelos Moleculares , Solubilidad
13.
Regul Toxicol Pharmacol ; 55(3): 330-9, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19686793

RESUMEN

In 1993, based on observations of subclinical neurological effects in workers, the United States Environmental Protection Agency (US EPA) published a Reference Concentration (RfC) of 0.05 microg/m(3) for manganese (Mn). The geometric mean exposure concentration, 150 microg/m(3) respirable Mn, was considered the lowest observable adverse effect level (LOAEL), and uncertainty factors (UFs) were applied to account for sensitive populations, database limitations, a LOAEL, subchronic exposure, and potential differences in toxicity of different forms of Mn. Based on a review of more recent literature, we propose two alternate Mn RfCs. Of 12 more recent occupational studies of eight cohorts with chronic exposure durations, examining subclinical neurobehavioral effects, predominantly on the motor system, three were considered appropriate for development of an RfC. All three studies yielded no observable adverse effect levels (NOAELs) of approximately 60 microg/m(3) respirable Mn. Converting the occupational NOAEL to a human equivalent concentration (HEC) of 21microg/m(3) (for continuous exposure) and applying a UF of 10 to account for intraspecies variability yielded an RfC of 2microg/m(3). We also derived a similar RfC (7 microg/m(3)) using an Mn benchmark dose (BMD) as the point of departure. Overall confidence in both RfCs is medium.


Asunto(s)
Contaminantes Ocupacionales del Aire/toxicidad , Manganeso/toxicidad , Síndromes de Neurotoxicidad/etiología , Exposición Profesional/análisis , Contaminantes Ocupacionales del Aire/química , Animales , Benchmarking , Monitoreo del Ambiente/métodos , Humanos , Manganeso/química , Nivel sin Efectos Adversos Observados , Valores de Referencia , Medición de Riesgo , Especificidad de la Especie , Estados Unidos , United States Environmental Protection Agency
14.
Eur J Med Chem ; 182: 111588, 2019 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-31421630

RESUMEN

Intrinsically disordered proteins are an emerging class of proteins without a folded structure and currently disorder-based drug targeting remains a challenge. p53 is the principal regulator of cell division and growth whereas MDM2 consists its main negative regulator. The MDM2-p53 recognition is a dynamic and multistage process that amongst other, employs the dissociation of a transient α-helical N-terminal ''lid'' segment of MDM2 from the proximity of the p53-complementary interface. Several small molecule inhibitors have been reported to inhibit the formation of the p53-MDM2 complex with the vast majority mimicking the p53 residues Phe19, Trp23 and Leu26. Recently, we have described the transit from the 3-point to 4-point pharmacophore model stabilizing this intrinsically disordered N-terminus by increasing the binding affinity by a factor of 3. Therefore, we performed a thorough SAR analysis, including chiral separation of key compound which was evaluated by FP and 2D NMR. Finally, p53-specific anti-cancer activity towards p53-wild-type cancer cells was observed for several representative compounds.


Asunto(s)
Antineoplásicos/farmacología , Proteínas Intrínsecamente Desordenadas/antagonistas & inhibidores , Proteínas Proto-Oncogénicas c-mdm2/antagonistas & inhibidores , Proteína p53 Supresora de Tumor/antagonistas & inhibidores , Antineoplásicos/síntesis química , Antineoplásicos/química , Bencilaminas/síntesis química , Bencilaminas/química , Bencilaminas/farmacología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Cianuros/síntesis química , Cianuros/química , Cianuros/farmacología , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Formiatos/síntesis química , Formiatos/química , Formiatos/farmacología , Humanos , Indoles/síntesis química , Indoles/química , Indoles/farmacología , Proteínas Intrínsecamente Desordenadas/química , Proteínas Intrínsecamente Desordenadas/metabolismo , Estructura Molecular , Proteínas Proto-Oncogénicas c-mdm2/química , Proteínas Proto-Oncogénicas c-mdm2/metabolismo , Relación Estructura-Actividad , Proteína p53 Supresora de Tumor/química , Proteína p53 Supresora de Tumor/metabolismo
15.
Toxicol Appl Pharmacol ; 232(3): 359-68, 2008 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-18687352

RESUMEN

Quantitative biologically-based models describing key events in the continuum from arsenic exposure to the development of adverse health effects provide a framework to integrate information obtained across diverse research areas. For example, genetic polymorphisms in arsenic metabolizing enzymes can lead to differences in target tissue dosimetry for key metabolites causative in toxic and carcinogenic response. This type of variation can be quantitatively incorporated into pharmacokinetic (PK) models and used together with population-based modeling approaches to evaluate the impact of genetic variation in methylation capacity on dose of key metabolites to target tissue. The PK model is an essential bridge to the pharmacodynamic (PD) models. A particular benefit of PD modeling for arsenic is that alternative models can be constructed for multiple proposed modes of action for arsenicals. Genomics data will prove useful for identifying the key pathways involved in particular responses and aid in determining other types of data needed for quantitative modeling. These models, when linked with PK models, can be used to better understand and explain dose- and time-response behaviors. This in turn assists in prioritizing modes of action with respect to their risk assessment relevance and future research. This type of integrated modeling approach can form the basis for a highly informative mode-of-action directed risk assessment for inorganic arsenic (iAs). This paper will address both practical and theoretical aspects of integrating PK and PD data in a modeling framework, including practical barriers to its application.


Asunto(s)
Arsénico/farmacocinética , Arsénico/toxicidad , Modelos Biológicos , Medición de Riesgo , Relación Dosis-Respuesta a Droga , Variación Genética , Humanos , Matemática , Metilación , Estado Nutricional , Factores Sexuales
16.
Bioorg Med Chem Lett ; 18(14): 4115-7, 2008 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-18583128

RESUMEN

A multi-component reaction strategy was used for the fast and efficient synthesis of amide isosteres of known Bcl-2 inhibitors capable of disrupting protein-protein interactions. Ugi reaction and a subsequent nucleophilic aromatic substitution reaction provide a versatile path to libraries of compounds similar to Abbott's acylsulfonamides. Modeling arguments are used to explain the inferior activity of the amide as opposed to the sulfonamide series.


Asunto(s)
Proteína bcl-X/antagonistas & inhibidores , Amidas/química , Apoptosis , Química Farmacéutica/métodos , Cianuros/química , Diseño de Fármacos , Humanos , Modelos Químicos , Modelos Moleculares , Conformación Molecular , Neoplasias/metabolismo , Péptidos/química , Proteínas/química , Relación Estructura-Actividad , Sulfonamidas/química , Proteína bcl-X/química
17.
Chemosphere ; 66(3): 496-504, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16870233

RESUMEN

Chromated copper arsenate (CCA) treated wood has been used for more than 50 years. Recent attention has been focused on appropriate disposal of CCA-treated wood when its service life ends. Groups in the US and Europe concerned with the possibility of arsenic migration to groundwater from disposed CCA-treated wood have proposed that consumers be required to dispose of the wood as a hazardous waste, in the most protective of landfills. We examined available data for evidence of arsenic migration from unlined construction and demolition (C&D) debris landfills in Florida, where CCA-treated wood is disposed. Florida was chosen because soil, groundwater, landfill design, weather, and levels of CCA-treated wood use make the state a uniquely sensitive indicator for observing arsenic migration from CCA-treated wood disposal sites, should it occur. We developed and quality-checked a CCA-treated wood disposal model to estimate the amount of wood and associated arsenic disposed. By 2000, an estimated 13 million kg of arsenic in CCA-treated wood was disposed in Florida; however, groundwater monitoring data do not indicate that arsenic is migrating from unlined C&D landfills. Our results provide evidence that highly stringent regulation of CCA-treated wood disposal, such as treatment as a hazardous waste, is unnecessary.


Asunto(s)
Arseniatos/química , Eliminación de Residuos/métodos , Madera/química , Arseniatos/análisis , Monitoreo del Ambiente/métodos , Florida , Modelos Teóricos , Reproducibilidad de los Resultados , Contaminantes del Agua/análisis , Contaminantes del Agua/química , Madera/análisis
18.
J Clin Endocrinol Metab ; 91(7): 2721-4, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16636123

RESUMEN

CONTEXT: Perchlorate has been detected in U.S. drinking water supplies at levels ranging from 4 to 200 microg/liter as well as in agricultural products. Perchlorate is known to be a competitive inhibitor of iodine uptake by the thyroid through the sodium-iodide symporter. OBJECTIVE: The objective of the study was to determine whether prolonged exposure (6 months) to low levels of perchlorate would perturb thyroid function. DESIGN: This was a prospective, double-blinded, randomized trial. PARTICIPANTS: The study population consisted of 13 healthy volunteers. INTERVENTION: INTERVENTIONs included placebo vs. 0.5 mg or 3.0 mg potassium perchlorate daily. MAIN OUTCOME MEASURES: Serum thyroid function tests, 24-h radioactive iodine uptake, serum thyroglobulin (Tg), urinary iodine and perchlorate, and serum perchlorate were measured. RESULTS: Mean urinary perchlorate value during ingestion of 0.5 mg perchlorate daily was 332.7 +/- 66.1 microg per 24 h or 248.5 +/- 64.5 microg/g creatinine and mean values for the four subjects who received 3 mg perchlorate daily were 2079.5 +/- 430.0 microg per 24 h or 1941.7 +/- 138.5 microg/g creatinine. There was no significant change in the thyroid (123)I uptakes during perchlorate administration. There were no significant changes in serum T(3), free T(4) index, TSH, or Tg concentrations during the exposure period, compared to baseline or postexposure values. Urine iodine values for the 3-mg perchlorate group were higher, but not significantly so, at baseline than during perchlorate exposure. CONCLUSIONS: We observed that a 6-month exposure to perchlorate at doses up to 3 mg/d had no effect on thyroid function, including inhibition of thyroid iodide uptake as well as serum levels of thyroid hormones, TSH, and Tg.


Asunto(s)
Percloratos/administración & dosificación , Glándula Tiroides/efectos de los fármacos , Glándula Tiroides/fisiología , Adulto , Anciano , Método Doble Ciego , Femenino , Humanos , Yodo/orina , Radioisótopos de Yodo , Masculino , Persona de Mediana Edad , Percloratos/farmacocinética , Percloratos/toxicidad , Estudios Prospectivos , Tiroglobulina/sangre , Tirotropina/sangre , Tiroxina/sangre , Triyodotironina/sangre
19.
Neurotoxicology ; 27(4): 520-4, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16551479

RESUMEN

Recent literature [e.g. Canfield RL, Henderson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10mg per deciliter. New Engl J Med 2003;348(16):1517-1526; Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, Canfield RL, Dietrich KN, Bornschein R, Greene T, Rothenberg SJ, Needleman HL, Schnaas L, Wasserman G, Graziano J, Roberts R. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 2005;113(7):894-899] has suggested the existence of a supra-linear dose-response relationship between environmental measures such as blood lead concentrations and IQ. This communication explores the mathematical requirements placed on such dose-response relationships when the environmental measure, or independent variable, is lognormally distributed and the effect, or dependent variable, is normally distributed. Results of the analyses show that a supra-linear slope is a required outcome of correlations between data distributions where one is lognormally distributed and the other is normally distributed. The analysis shows that caution should be taken in assigning biological significance to supra-linear dose-response relationships in these instances. Detailed analyses of such data sets should be conducted to determine if the magnitude of supra-linear slopes are more or less than mathematically required, and from there to consider biological significance.


Asunto(s)
Inteligencia/efectos de los fármacos , Plomo/sangre , Plomo/toxicidad , Dinámicas no Lineales , Estadística como Asunto , Relación Dosis-Respuesta a Droga , Humanos , Inteligencia/fisiología
20.
Phys Med Biol ; 50(22): 5281-91, 2005 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-16264253

RESUMEN

In this paper, numerical simulations are used in an attempt to find optimal source profiles for high frequency radiofrequency (RF) volume coils. Biologically loaded, shielded/unshielded circular and elliptical birdcage coils operating at 170 MHz, 300 MHz and 470 MHz are modelled using the FDTD method for both 2D and 3D cases. Taking advantage of the fact that some aspects of the electromagnetic system are linear, two approaches have been proposed for the determination of the drives for individual elements in the RF resonator. The first method is an iterative optimization technique with a kernel for the evaluation of RF fields inside an imaging plane of a human head model using pre-characterized sensitivity profiles of the individual rungs of a resonator; the second method is a regularization-based technique. In the second approach, a sensitivity matrix is explicitly constructed and a regularization procedure is employed to solve the ill-posed problem. Test simulations show that both methods can improve the B(1)-field homogeneity in both focused and non-focused scenarios. While the regularization-based method is more efficient, the first optimization method is more flexible as it can take into account other issues such as controlling SAR or reshaping the resonator structures. It is hoped that these schemes and their extensions will be useful for the determination of multi-element RF drives in a variety of applications.


Asunto(s)
Procesamiento de Imagen Asistido por Computador/métodos , Imagen por Resonancia Magnética/métodos , Modelos Teóricos , Simulación por Computador , Imagen por Resonancia Magnética/instrumentación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA